Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-47.06%
↓ 90% below average
Average (9y)
-24.79%
Historical baseline
Range
High:12.46%
Low:-63.50%
CAGR
+30.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -47.06% | +25.9% |
| 2023 | -63.50% | -575.9% |
| 2022 | -9.39% | +70.7% |
| 2021 | -32.03% | -597.3% |
| 2020 | -4.59% | +83.3% |
| 2019 | -27.49% | +54.4% |
| 2018 | -60.22% | -408.1% |
| 2017 | -11.85% | -195.2% |
| 2016 | 12.46% | +397.5% |
| 2015 | -4.19% | - |